Metrics to compare | RAMM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAMMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −2.7x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.4x | 0.6x | 2.6x | |
Price / LTM Sales | 0.7x | 0.8x | 3.2x | |
Upside (Analyst Target) | - | 59.1% | 48.1% | |
Fair Value Upside | Unlock | 22.9% | 6.6% | Unlock |
RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.